selected scholarly activity
-
books
-
chapters
- Bipolar Disorders 2021
- Intracortical myelination. 417-426. 2021
- Bipolar Disorder in Women: Menstrual Cycle, Perinatal Period, and Menopause Transition. 59-71. 2020
- Oncodynamic Effect of Cancer on Depression. 105-127. 2016
- Neuroimaging and illness progression. 145-174. 2015
- Predictors of treatment response in bipolar disorder: lessons from longitudinal studies. 61-70. 2015
- Depression and the menstrual cycle. 220-233. 2013
- Bipolar Disorder in Women. 463-476. 2010
- Quality of Life in Bipolar Disorder. 3591-3606. 2010
-
conferences
- Factors associated with suicide risk in young women with premenstrual dysphoric disorder: A population-based study. Trends in Psychiatry and Psychotherapy. 114-114. 2024
- A Network Control Theory Approach to Relapse Prediction in Major Depressive Disorder: A Report From the CAN-BIND-1 Trial and Wellness Monitoring Study. Neuropsychopharmacology. 231-231. 2023
- Cognitive Behavioural Therapy for Sexual Concerns During Peri- and Post-Menopause: Preliminary Outcomes. Menopause. 1265-1265. 2023
- Intrinsic Network Disruptions in Major Depressive Disorder Revealed by Whole-Brain Functional Connectivity Multi-Voxel Pattern Analysis. Neuropsychopharmacology. 256-257. 2023
- Polygenic Risk Score Analysis of Antidepressant Treatment Response: Results From the CAN-BIND-1 Cohort. Neuropsychopharmacology. 238-238. 2023
- LATE-BREAKING REWARD-BASED EEG BIOMARKERS IN PREDICTING TREATMENT OUTCOME IN MAJOR DEPRESSIVE DISORDER: A CANADIAN BIOMARKER INTEGRATION NETWORK FOR DEPRESSION STUDY (CAN-BIND-1). Psychophysiology. S142-S143. 2023
- Biological rhythm disruptions in a school-based sample of children of mothers with bipolar disorder. Bipolar Disorders. 52-52. 2023
- Biological rhythms disruption mediates the association between mother's diagnosis of bipolar disorder and children's emotional and behavioral problems. Bipolar Disorders. 55-55. 2023
- Evaluation of mesencephalic astrocyte-derived neurotrophic factor serum levels in mood disorders. Bipolar Disorders. 58-58. 2023
- Increased neurofilament light chain in individuals with bipolar disorder. Bipolar Disorders. 60-61. 2023
- Intranasal mesencephalic astrocyte-derived neurotrophic factor (MANF) as a novel treatment for bipolar disorder. Bipolar Disorders. 41-41. 2023
- Lifestyle modifications and non-pharmacological interventions to support perinatal mental health. Bipolar Disorders. 21-21. 2023
- Love and madness: Living with bipolar disorder. Bipolar Disorders. 20-21. 2023
- Mood symptoms and suicidality among offspring of mothers with bipolar disorder: A school-based sample. Bipolar Disorders. 115-115. 2023
- Genetic Polymorphism of Brain-Derived Neurotrophic Factor is Related to Antidepressant Efficacy and Treatment-Induced Hippocampal Plasticity in Patients With Major Depressive Disorder: CAN-BIND-1 Study. Biological Psychiatry. S209-S209. 2023
- Pro-inflammatory markers predict response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report. European psychiatry. S295-S295. 2023
- Predictors of illicit substance abuse/dependence during young adulthood: A machine learning approach. Journal of Psychiatric Research. 168-173. 2023
- EFFECTS OF CYP2C19, CYP2D6, AND ABCB1 GENE VARIANTS ON ESCITALOPRAM AND ARIPIPRAZOLE TREATMENT-RELATED SEXUAL SIDE EFFECTS: RESULTS FROM THE CAN-BIND-1 STUDY. European Neuropsychopharmacology. e166-e167. 2022
- A novel neurobiological pathway behind psychosocial functioning in bipolar I disorder. Bipolar Disorders. 32-32. 2022
- Integrating biorhythm subtypes in a clinical subtype model of bipolar disorders. Bipolar Disorders. 59-59. 2022
- Defining Subtypes of Escitalopram Response Using Resting-State fMRI. Biological Psychiatry. S51-S51. 2022
- Passive Behavior Sensing Features and Depression Characteristics in a Prospective Relapse Monitoring Study. Biological Psychiatry. S189-S189. 2022
- Peripheral Inflammation as a Marker of Response to Sequential Pharmacotherapy in Major Depressive Disorder: A CAN-BIND-1 Study. Biological Psychiatry. S86-S87. 2022
- Replication of Personalized Relapse Prediction in Patients With Major Depressive Disorder Using Digital Biomarkers. Biological Psychiatry. S241-S242. 2022
- Investigating biological rhythms disruptions across the menstrual cycle in women with comorbid bipolar disorder and premenstrual dysphoric disorder. Archives of Women's Mental Health. 345-353. 2022
- Functional and cognitive impairment in the first episode of depression: A systematic review. Acta Psychiatrica Scandinavica. 156-185. 2022
- The association between a history of childhood maltreatment and depression in midlife women. Menopause. 1471-1471. 2021
- Risk factors for new-onset bipolar disorder in a community cohort: A five-year follow up study. Psychiatry Research. 2021
- Identifying nonlinear patterns of 5-year suicide risk incidence in youth: A gradient tree boosting and SHAP study. Bipolar Disorders. 100-100. 2021
- Relationships between affective, somatic, and cognitive symptoms against validated scores of anxiety and depression: A prospective preliminary study. Bipolar Disorders. 74-74. 2021
- Validating the 3-item biological rhythms interview of assessment in neuropsychiatry chronotype measure against actigraphy and the Munich chronotype questionnaire. Bipolar Disorders. 78-78. 2021
- Daily Variability in Affective, Somatic, and Cognitive Symptoms Against Validated Scores of Anxiety and Depression: A Prospective Preliminary Study. Biological Psychiatry. S111-S111. 2021
- Depth-Specific Changes in Age-Related Trajectory of Intracortical Myelin in Bipolar Disorder. Biological Psychiatry. S273-S273. 2021
- Identifying Nonlinear Patterns of 5-Year Suicide Risk Incidence in Youth: A Gradient Tree Boosting and SHAP Study. Biological Psychiatry. S283-S283. 2021
- Risk Factors for New-Onset Bipolar Disorder in a Community Cohort: A Five-Year Follow up Study. Biological Psychiatry. S316-S316. 2021
- Sleep Parameters of Offspring of Mothers With Bipolar Disorder as Compared to Offspring of Mothers Without Mood Disorders. Biological Psychiatry. S134-S134. 2021
- Biological rhythms disruption in comorbid bipolar disorder and premenstrual dysphoric disorder. Bipolar Disorders. 102-102. 2020
- Chronobiologic assessment methods for bipolar disorders: current research protocols and clinical applications. Bipolar Disorders. 41-42. 2020
- Daily variation of cognitive, affective and somatic factors that are related to mood disorders in adolescents. Bipolar Disorders. 68-68. 2020
- Investigating light exposure and transition probabilities as variables of interest in mood disorders. Bipolar Disorders. 44-44. 2020
- Investigating the use of cannabinoids for insomnia in individuals with depression and anxiety. Bipolar Disorders. 82-83. 2020
- Modeling severity of postpartum depression using objective and subjective sleep and biological rhythms: A machine learning approach. Bipolar Disorders. 95-95. 2020
- Relationship between epigenetic markers and hypothalamus volumes in major depressive disorder. Bipolar Disorders. 57-57. 2020
- The mood rhythm instrument: A chronobiological approach to evaluate mood in clinical settings. Bipolar Disorders. 94-94. 2020
- Pre-Treatment Resting-State Functional Connectivity Related to Anhedonia and Anxiety are Associated With Antidepressant Response to Escitalopram and Adjunct Aripiprazole. Biological Psychiatry. S431-S431. 2020
- Exploring the Genetic Architecture of Mood Symptoms in Postpartum Depression and Postpartum Psychosis Using Polygenic Risk Scores. Neuropsychopharmacology. 229-229. 2019
- M31 IMPACT OF CYP2C19 AND CYP2D6 GENE VARIANTS ON PLASMA LEVELS AND TREATMENT RESPONSE IN PATIENTS RECEIVING ESCITALOPRAM AND ARIPIPRAZOLE FOR MAJOR DEPRESSION: RESULTS FROM THE CAN-BIND-1 COHORT. European Neuropsychopharmacology. S183-S183. 2019
- CANNABIDIOL AS A NOVEL CANDIDATE ALCOHOL USE DISORDER PHARMACOTHERAPY: A SYSTEMATIC REVIEW. Alcoholism: Clinical and Experimental Research. 249A-249A. 2019
- F107. Cortical Thickness Features Differentiate 16-Week Antidepressant Response Profiles in Major Depressive Disorder. Biological Psychiatry. S254-S254. 2019
- F113. Hippocampal Subfield-Specific Sex Differences in Patients With Major Depressive Disorder. Biological Psychiatry. S257-S257. 2019
- F119. Age Trajectory of Deep White Matter Intensity in Bipolar Disorder Type-I Using MRI. Biological Psychiatry. S259-S259. 2019
- S124. Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the Can-Bind Cohort. Biological Psychiatry. S344-S345. 2019
- T97. Predicting Functioning and Quality of Life Using Objective and Subjective Measures of Sleep and Biological Rhythms in Major Depressive and Bipolar Disorder. Biological Psychiatry. S166-S166. 2019
- Diagnosis and treatment of women with co-morbid bipolar and premenstrual dysphoric disorder. Bipolar Disorders. 53-54. 2019
- Explicit emotional memory in major depressive disorder during euthymia. Bipolar Disorders. 150-151. 2019
- Intracortical Myelin as a novel neurobiological correlate of psychosocial functioning in bipolar I disorder. Bipolar Disorders. 76-77. 2019
- Lifetime cocaine use predicts conversion from major depressive disorder to bipolar disorder: A prospective 3-year follow-up study. Bipolar Disorders. 95-96. 2019
- Management of bipolar disorder in pregnancy and the postpartum period. Bipolar Disorders. 49-50. 2019
- Predicting functioning and quality of life using objective and subjective measures of sleep and biological rhythms in major depressive and bipolar disorder. Bipolar Disorders. 58-58. 2019
- The influence of endogenous DHEAS on mood in women with bipolar disorder with and without comorbid PMDD. Bipolar Disorders. 61-61. 2019
- Trauma, cocaine use and female sex predict transition from major depression to bipolar disorder. Bipolar Disorders. 56-56. 2019
- Escitalopram Response is Associated With Pre-Treatment Neuraland Clinical Correlates of Anhedonia. Neuropsychopharmacology. S127-S128. 2018
- Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the Can-Bind Cohort. Neuropsychopharmacology. S118-S119. 2018
- S120. Canadian Biomarker Integration Network in Depression (CAN-BIND): Baseline and Follow up Neurocognitive Mediators of Functioning in Major Depressive Disorder (MDD). Biological Psychiatry. S393-S394. 2018
- S34. New Onset Anxiety and Anxiety Exacerbation in the Perinatal Period: A Systematic Review and Meta-Analysis. Biological Psychiatry. S360-S360. 2018
- Brain structure and function in women with co-morbid bipolar and premenstrual dysphoric disorder. Bipolar Disorders. 55-55. 2018
- Correlations between endogenous hormones and resting-state functional connectivity in bipolar disorder with and without comorbid premenstrual dysphoric disorder. Bipolar Disorders. 75-76. 2018
- Emotional memory in bipolar disorder and major depressive disorder: a preliminary report. Bipolar Disorders. 102-103. 2018
- Objective sleep and daytime activity in bipolar and major depressive disorder. Bipolar Disorders. 20-21. 2018
- The impact of female reproductive life events on women with bipolar disorder: a clinical perspective. Bipolar Disorders. 26-26. 2018
- VItex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Bipolar Disorders. 140-140. 2018
- Effects of Tryptophan Depletion on Mood, Vasomotor Symptoms and Sleep in Midlife Women on Estrogen Therapy: Double Blind Placebo-Controlled Crossover Trial. Menopause. 1460-1461. 2017
- The Effects of Acute Tryptophan Depletion on Emotional Stroop in Midlife Women Receiving Estrogen-based Treatment: An fMRI study. Menopause. 1453-1453. 2017
- Childhood maltreatment and markers of neuroinflammation predict response to anti-depressant treatment in adults with major depressive disorder. Psychoneuroendocrinology. 73-73. 2017
- 468. Impact of Biological Rhythms on Perinatal Anxiety: A Prospective Investigation in Pregnant Women with Mood Disorders. Biological Psychiatry. S191-S191. 2017
- A 24-week randomized, placebo-controlled trial of adjunctive tianeptine in the maintenance treatment of bipolar disorder. Bipolar Disorders. 119-119. 2017
- Anti-inflammatory drugs in the treatment of major depression: a systematic review. Bipolar Disorders. 120-120. 2017
- Changes in biological rhythms and mood from pregnancy to early postpartum in women with mood disorders: preliminary results. Bipolar Disorders. 139-139. 2017
- Circadian rhythmopathy - a shared timer for dopamine - dependent features in bipolar disorder? biological rhythms across the perinatal period in women with mood disorders: a longitudinal, replication and expansion study. Bipolar Disorders. 38-39. 2017
- Earlier illness onset and increased hormonal sensitivity in women with co-morbid bipolar and premenstrual dysphoric disorder: clinical and treatment implications. Bipolar Disorders. 60-60. 2017
- Evidence of deficits in intracortical maturation in bipolar I disorder: a 3T MRI study. Bipolar Disorders. 33-33. 2017
- Global deficits in intracortical myelin maturation in young adults with bipolar I disorder. Bipolar Disorders. 80-80. 2017
- Increased illness burden in women with co-morbid bipolar and premenstrual dysphoric disorder: data from the large step-BD study. Bipolar Disorders. 90-90. 2017
- Neurobiological correlates of co-morbid bipolar and premenstrual dysphoric disorder. Bipolar Disorders. 83-83. 2017
- Impact of Tryptophan Depletion on Sleep Efficiency during the Menopausal Transition while on Estrogen Therapy: Preliminary Results. Menopause. 1394-1395. 2016
- Resting-state fMRI after Acute Tryptophan Depletion in Perimenopause Women on Estrogen Therapy: Preliminary Results. Menopause. 1400-1400. 2016
- Validation of the Menopause Visual Analogue Scale in Determining Mood and Physical Symptoms of Perimenopausal Women on Estrogen Treatment. Menopause. 1395-1395. 2016
- Diagnostic accuracy of measures evaluating premenstrual dysphoric disorder in women with comorbid bipolar and major depressive disorder. Bipolar Disorders. 162-163. 2016
- Intracortical myelin content in the DLPFC predicts verbal memory, and self-reported cognitive and psychosocial functioning in bipolar disorder. Bipolar Disorders. 74-74. 2016
- Objective parameters of sleep and circadian rhythms: an actigraph and melatonin study in bipolar and major depressive disorder. Bipolar Disorders. 45-45. 2016
- Prospective investigation of subjective measures of biological rhythms across the perinatal period in women with bipolar disorder. Bipolar Disorders. 163-163. 2016
- Resting state prefrontal cortical connectivity in women with bipolar disorder during euthymia: a seed-based analysis. Bipolar Disorders. 74-74. 2016
- Neural Correlates of Resting State Functional Connectivity in Women with Bipolar Disorder in Remission: An ICA and Seed Based Analysis. Biological Psychiatry. 120S-120S. 2016
- Objective Validation of the Biological Rhythms Interview for Assessment in Neuropsychiatry (BRIAN): Preliminary Analyses. Biological Psychiatry. 55S-55S. 2016
- Resting State Functional Connectivity and Emotional Stroop Activation Across the Menstrual Cycle in Women with no History of PMDD. Biological Psychiatry. 242S-242S. 2016
- Examining Differences in Cortical Thickness in Perimenopausal Middle Aged Females with Major Depressive Disorder and Healthy Controls. Menopause. 1389-1390. 2015
- Hippocampal volumetric analysis in unmedicated midlife women with major depressive disorder. Menopause. 1390-1391. 2015
- Cerebral dopamine neurotrophic factor (CDNF) levels are increased in bipolar disorder. Bipolar Disorders. 100-100. 2015
- Co-morbid bipolar and premenstrual dysphoric disorder: from hormones to brain circuits and behavior. Bipolar Disorders. 48-48. 2015
- Differences in resting state connectivity between follicular and luteal menstrual cycle phases in euthymic women with bipolar disorder. Bipolar Disorders. 126-126. 2015
- Longitudinal assessment of circadian rhythms in women at risk for postpartum depression. Bipolar Disorders. 27-27. 2015
- MAC-PMSS: preliminary analyses of a new DSM-5-based tool to monitor concurrent mood and premenstrual symptoms. Bipolar Disorders. 120-121. 2015
- Women with history of mood disorders show greater circadian rhythm disruption across the perinatal period: preliminary analyses of a longitudinal study. Bipolar Disorders. 108-108. 2015
- Changes in Grey and White Matter Volume in Midlife in Men and Women with Major Depressive Disorder. Biological Psychiatry. 2015
- Circadian Phase-Delay During Pregnancy Predicts the Severity of Postpartum Depressive Symptoms in Women at Risk for Postpartum Depression. Biological Psychiatry. 390S-390S. 2015
- Discrepancy Between Subjective and Objective Parameters of Sleep and Biological Rhythms in Pregnant Women with Mood Disorders. Biological Psychiatry. 2015
- Alterations in Biological Rhythms but not Sleep Quality Predict Severity of Depressive Symptoms in Late Pregnancy. Biological Psychiatry. 126S-126S. 2014
- Cognitive Profile of Obese Adults with and without a Mood Disorder. Biological Psychiatry. 55S-55S. 2014
- Emotional Memory in Pregnant Women with and Without Major Depression. Biological Psychiatry. 197S-197S. 2014
- Lack of Concordance between Multiplex and Enzyme-Linked Immunosorbent Assay in the Measurement of Cytokines in Human Serum: Implications for Studies of Low-Grade Systemic Inflammation. Biological Psychiatry. 384S-384S. 2014
- The Impact of Pre-Pregnancy Body Mass Index on Autonomic Function and Circadian Rhythms during Pregnancy: Preliminary Results. Biological Psychiatry. 268S-268S. 2014
- Circadian rhythm disruption in women with bipoloar and premenstrual dysphoric disorder during remission: preliminary results. Journal of Women's Health. 17-18. 2014
- Serum Myelin Oligodendrocyte Glycoprotein Levels are Stable in Depressed Females with Bipolar Disorder. Journal of Women's Health. 17-17. 2014
- Circadian rhythm disruption in women with bipolar and premenstrual dysphoric disorder during remission: preliminary results. Bipolar Disorders. 77-77. 2014
- Does pregnancy affect circadian rhythms in women with mood disorders during remission?. Bipolar Disorders. 77-78. 2014
- Serum myelin oligodendrocyte glycoprotein levels are stable in depressed females with bipolar disorder. Bipolar Disorders. 72-72. 2014
- P.2.d.009 The predictive role of Val66Met polymorphism on levels of BDNF along treatment of medication-free patients with bipolar disorder. European Neuropsychopharmacology. S367-S368. 2013
- A double challenge: pregnancy and post-partum in bipolar disorder. Bipolar Disorders. 156-156. 2013
- Circadian rhythm is a strong predictor of quality of life in females with bipolar disorder. Bipolar Disorders. 107-107. 2013
- Longitudinal assessment of changes in circadian rhythms and risk for postpartum depression: a preliminary analysis. Bipolar Disorders. 107-107. 2013
- Markers of lipid peroxidation are not altered in depressed and euthymic females with bipolar disorder. Bipolar Disorders. 56-56. 2013
- Depression and Cardiovascular Disease in Women: Does This Comorbidity Have an Immunological Basis? A Theoretical Synthesis. Biological Psychiatry. 325S-325S. 2013
- Depressive Symptoms in Late Pregnancy are Associated with a Systemic Pro-Inflammatory Cytokine Profile. Biological Psychiatry. 325S-325S. 2013
- Heightened Systemic Inflammation: A State or a Trait Marker for Major Depression During Late Pregnancy?. Biological Psychiatry. 203S-203S. 2013
- Heightened Systemic Inflammation: A State or a Trait Marker for Major Depression During Late Pregnancy?. Biological Psychiatry. 313S-313S. 2013
- Impact of Circadian Rhythm, Sleep Quality and Depression Severity on Quality of Life in Females with Bipolar Disorder. Biological Psychiatry. 59S-59S. 2013
- Impact of Estrogen Levels and Severity of Depressive Symptoms on Brain Cortical Thickness in Unmedicated Peri/Postmenopausal Women with Depression. Biological Psychiatry. 186S-186S. 2013
- Blood Contamination in the Measurement of Salivary Hormones in Healthy Women. Biological Psychiatry. 285S-285S. 2012
- Changes in Cortical Thickness Across Adulthood in Major Depressive Disorder. Biological Psychiatry. 199S-200S. 2012
- Mechanistic Pathways for the Antidepressant Effects of Estradiol in Perimenopausal Women with MDD: An Acute Tryptophan Depletion, fMRI Proof-of-Concept. Biological Psychiatry. 200S-200S. 2012
- Peripheral Biomarkers in New Onset of Major Depressive Disorder in Midlife Women: The Harvard Study of Moods and Cycles. Biological Psychiatry. 278S-278S. 2012
- Severity of Depressive Symptoms in Late Pregnancy Depends on the Interaction Between Circadian Rhythm and Sleep Disturbances. Biological Psychiatry. 278S-278S. 2012
- A functional MRI investigation of the neural correlates of declarative and recognition memory in obese patients with bipolar disorder. Bipolar Disorders. 117-117. 2012
- Default mode network in children at risk for bipolar disorder: preliminary resting-state fMRI findings. Bipolar Disorders. 83-83. 2012
- Sensitivity and specificity of the Mood Disorders Questionnaire as a screening for bipolar disorder during pregnancy and postpartum. Bipolar Disorders. 41-41. 2012
- BRAIN-DERIVED NEUROTROPHIC FACTOR AS A BIOMARKER OF CLINICAL RESPONSE IN BIPOLAR DISORDER: 16 WEEK FOLLOW-UP STUDY. European psychiatry. 2012
- Antidepressant Effects on Brain Activation During the Emotional Conflict Task in Perimenopausal Women: a Functional MRI Study. Menopause. 1371-1371. 2011
- Cortical Thickness Analysis in Depressed, Medication-free, Perimenopausal and Postmenopausal Women. Menopause. 1348-1349. 2011
- Effects of Quetiapine Extended-Release on Sleep and Quality of Life in Midlife Women With Major Depressive Disorder. Menopause. 1371-1371. 2011
- A longitudinal assessment of serum Brain Derived Neurotrophic Factor levels in bipolar patients. Bipolar Disorders. 51-51. 2011
- An Exploration of the Impact of Weight Loss on Declarative Memory and Executive Functioning in Bipolar and Major Depressive Disorders. Biological Psychiatry. 173S-173S. 2011
- Emotional Conflict in Offspring of Bipolar Parents - Preliminary fMRI Findings. Biological Psychiatry. 165S-165S. 2011
- Frontal Executive Attention Network in Medication-Free Women With Depression during Menopausal Transition: Normalization of Prefrontal Cortical Hyperactivation after Antidepressant Treatment. Biological Psychiatry. 181S-181S. 2011
- Are Neurocognitive Complaints Persistent During the Follicular Phase in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder?. Biological Psychiatry. 66S-66S. 2010
- Gene Expression of Estrogen Receptor alpha and Serotonin Transporter in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Biological Psychiatry. 55S-55S. 2010
- Imaging and Cognitive Tasks in Clinical Interventions for Female-Specific Mood Disorders. Biological Psychiatry. 174S-174S. 2010
- Neuronal Correlates of Regulation of Emotional Conflict in Women During Menopausal Transition. Biological Psychiatry. 137S-137S. 2010
- Making sense of findings of brain imaging in bipolar disorder. Bipolar Disorders. 60-60. 2010
- Shift in the brain network of emotional regulation in midlife women: Is the menopausal transition the turning point?. International Journal of Neuropsychopharmacology. 44-44. 2010
- Brain-derived neurotrophic factor levels and cognitive dysfunction in euthymic bipolar type I patients. Bipolar Disorders. 88-88. 2009
- DNA damage and apoptosis in bipolar and schizophrenia patients. Bipolar Disorders. 16-16. 2009
- ADVANCES IN THE PATHOPHYSIOLOGY OF EPISODE-RELATED COGNITIVE IMPAIRMENT IN BIPOLAR DISORDER. European psychiatry. 2009
- GENDER DIFFERENCES IN BRAIN SEROTONIN SYNTHESIS IN INDIVIDUALS WITH MAJOR DEPRESSIVE DISORDER: A A-[C-11]MT PET IMAGING STUDY. European psychiatry. 2009
- MIDLIFE WOMEN WITH MAJOR DEPRESSIVE DISORDER: EFFECTS OF QUETIAPINE EXTENDED-RELEASE ON MOOD, SLEEP AND MENOPAUSE-RELATED SYMPTOMS. European psychiatry. 2009
- Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: A combined α-[11C]MT and [18F]MPPF positron emission tomography study. NeuroImage. 850-857. 2008
- Correlation between serotonin synthesis and 5HT1A receptor binding: A combined a-[11C]MT and [18F]MPPF imaging study. International Journal of Neuropsychopharmacology. 100-100. 2008
- Three-Dimensional Mapping of Hippocampal Anatomy in Unmedicated and Lithium-Treated Patients with Bipolar Disorder. Neuropsychopharmacology. 1229-1238. 2008
- Sleep disturbance induced by amphetamine in a rodent model of mania. Sleep. A319-A319. 2008
- Effects of lithium and valproate on DNA damage and oxidative stress markers in an animal model. Bipolar Disorders. 16-16. 2007
- The use of clozapine in the treatment of bipolar disorder in a patient with clinical comorbidities. Bipolar Disorders. 37-38. 2007
- Brain-derived neurotrophic factor val66met polymorphism and morphometric abnormality in bipolar disorder patients. Biological Psychiatry. 141S-141S. 2007
- Cox-2 inhibitor (Celecoxib) as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: A double-blind, randomized, placebo-controlled study. Biological Psychiatry. 171S-171S. 2007
- Effects of BDNF val66met polymorphism on brain neurochemistry in bipolar disorder patients: A 1H MRS study. Biological Psychiatry. 59S-59S. 2007
- A cox-2 inhibitor (celecoxib) as a possible adjunctive agent to expedite treatment response in bipolar depression. Neuropsychopharmacology. S163-S164. 2006
- Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology. S148-S148. 2006
- A twin-case study of oxidative stress and DNA damage in bipolar disorder. Bipolar Disorders. 64-64. 2006
- Increased oxidative stress status in bipolar disorder. Bipolar Disorders. 64-64. 2006
- Quality of life and anxious comorbidity in bipolar patients. Bipolar Disorders. 51-51. 2006
- Serum content of GDNF is increased during manic and depressive episodes. Bipolar Disorders. 65-65. 2006
- Suicidal behavior and anxiety comorbidity affect psychosocial disability in bipolar disorder. Bipolar Disorders. 49-49. 2006
- Increased oxidative stress in submitochondrial particles after chronic d-amphetamine exposure. Biological Psychiatry. 58S-59S. 2006
- Induction of antioxidant defense enzymes after acute and chronic d-Amphetamine exposure. Biological Psychiatry. 142S-142S. 2006
- Lower creatine plus phosphocreatine in the left dorsolateral prefrontal cortex in unmedicated bipolar disorder subjects: A magnetic resonance spectroscopy study. Biological Psychiatry. 58S-58S. 2006
- Lower creatine plus phosphocreatine in the left dorsolateral prefrontal cortex in unmedicated bipolar disorder subjects: A magnetic resonance spectroscopy study. Biological Psychiatry. 141S-141S. 2006
-
journal articles
- Childhood maltreatment as a predictor of substance use/misuse among youth: A systematic review and meta-analysis.. Neuroscience and Biobehavioral Reviews. 166:105873. 2024
- Sleep and circadian disruption in bipolar disorders: From psychopathology to digital phenotyping in clinical practice.. Psychiatry and Clinical Neurosciences. 78:654-666. 2024
- Endocannabinoid concentrations in major depression: effects of childhood maltreatment and relation to hippocampal volume.. Translational Psychiatry. 14:431. 2024
- Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression study.. Translational Psychiatry. 14:432. 2024
- Biological rhythms in premenstrual syndrome and premenstrual dysphoric disorder: a systematic review.. BMC Women's Health. 24:551. 2024
- Early Life Trauma, Emotion Dysregulation and Hormonal Sensitivity Across Female Reproductive Life Events.. Current Psychiatry Reports. 26:530-542. 2024
- In situ-gelling hydrophobized starch nanoparticle-based nanoparticle network hydrogels for the effective delivery of intranasal olanzapine to treat brain disorders. International Journal of Biological Macromolecules. 277:134385-134385. 2024
- Towards Better Perinatal Mental Health Care.. Journal of Obstetrics and Gynaecology Canada. 46:102680. 2024
- Vers de meilleurs soins en santé mentale périnatale.. Journal of Obstetrics and Gynaecology Canada. 46:102681. 2024
- Safety of psychotropic medications in pregnancy: an umbrella review.. Molecular Psychiatry. 1-9. 2024
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. Canadian Journal of Psychiatry. 69:641-687. 2024
- Depression-Anxiety Coupling Strength as a predictor of relapse in major depressive disorder: A CAN-BIND wellness monitoring study report. Journal of Affective Disorders. 361:189-197. 2024
- Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Study. Pharmacopsychiatry. 57:232-244. 2024
- Publisher Correction: Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo. nature mental health. 2:1120-1120. 2024
- Atypical Brain Aging and Its Association With Working Memory Performance in Major Depressive Disorder. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 9:786-799. 2024
- Greater within- and between-day instability is associated with worse anxiety and depression symptoms. Journal of Affective Disorders. 356:215-223. 2024
- Assessing remission in major depressive disorder using a functional-structural data fusion pipeline: A CAN-BIND-1 study. IBRO Neuroscience Reports. 16:135-146. 2024
- Large Individual Differences in Functional Connectivity in the Context of Major Depression and Antidepressant Pharmacotherapy. eNeuro. 11:ENEURO.0286-23.2024. 2024
- An empirical analysis of structural neuroimaging profiles in a staging model of depression. Journal of Affective Disorders. 351:631-640. 2024
- Routine regularity during a global pandemic: Impact on mental health outcomes and influence of chronotype. Chronobiology International. 41:456-472. 2024
- Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study. Canadian Journal of Psychiatry. 69:183-195. 2024
- A systematic review of abnormalities in intracortical myelin across psychiatric illnesses. Journal of Affective Disorders Reports. 15:100689-100689. 2024
- Cognitive Behavioural Therapy for insomnia decreases the discrepancy between objective and subjective measures of sleep. Trends in Psychiatry and Psychotherapy. 2024
- Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder. BJPsych Open. 10:e18. 2024
- Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo. nature mental health. 2:164-176. 2024
- Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 report. European Neuropsychopharmacology. 78:71-80. 2024
- The association of blood biomarkers with cerebral white matter and myelin content in bipolar disorder: A systematic review. Revista Brasileira de Psiquiatria. 46:e20233267. 2024
- Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression. American Journal of Psychiatry. 180:884-895. 2023
- Predicting recurrence of major depressive episodes using the Depression Implicit Association Test: A Canadian biomarker integration network in depression (CAN-BIND) report. Psychiatry Research. 330:115606-115606. 2023
- Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report. CNS Spectrums. 28:739-746. 2023
- Machine Learning Prediction of Quality of Life Improvement During Antidepressant Treatment of Patients With Major Depressive Disorder. Journal of Clinical Psychiatry. 85:23m14864. 2023
- Changes in posttraumatic stress disorder symptom severity during the COVID-19 pandemic: Ten-wave findings from a longitudinal observational cohort study of community adults. Psychiatry Research. 329:115496-115496. 2023
- Delphi consensus study to develop guidelines for the management of adults with borderline personality disorder in the emergency department: a protocol. BMJ Open. 13:e075119-e075119. 2023
- Personalized relapse prediction in patients with major depressive disorder using digital biomarkers. Scientific Reports. 13:18596. 2023
- Lifestyle in bipolar disorder: A cross-sectional study. Revista de Psiquiatria y Salud Mental. 16:244-250. 2023
- A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study. Scientific Reports. 13:15300. 2023
- Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant Medication. JAMA network open. 6:e2336094-e2336094. 2023
- Lifestyle interventions for bipolar disorders: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews. 152:105257-105257. 2023
- Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report. Psychological Medicine. 53:5374-5384. 2023
- Response trajectories during escitalopram treatment of patients with major depressive disorder. Psychiatry Research. 327:115361-115361. 2023
- Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression. New England Journal of Medicine. 389:430-440. 2023
- A pilot study examining the effectiveness of a short-term, DBT informed, skills group for emotion dysregulation during the perinatal period.. Psychological Services. 20:697-707. 2023
- Periodicity and severity of changes in depression and anxiety during the COVID-19 pandemic: Ten-wave longitudinal findings from an observational cohort study of community adults. Psychiatry Research. 326:115267-115267. 2023
- The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report. Canadian Journal of Psychiatry. 68:586-595. 2023
- The comorbidity between Borderline Personality Disorder (BPD) and Generalized Anxiety Disorder (GAD): A systematic review and meta-analysis. Journal of Psychiatric Research. 164:304-314. 2023
- SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants. eLife. 12:e85316. 2023
- Cannabidiol as a candidate pharmacotherapy for sleep disturbance in alcohol use disorder. Alcohol and alcoholism (Oxford, Oxfordshire). Supplement. 58:337-345. 2023
-
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from theCAN‐BIND ‐1 Study. Clinical Pharmacology and Therapeutics. 114:88-117. 2023 - Atypical antipsychotic-induced mania: A systematic review and meta-analysis. Journal of Affective Disorders. 333:420-435. 2023
- The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 report. Psychiatry Research. 325:115222-115222. 2023
- Psychometric properties of the difficulties in emotion regulation Scale in a perinatal sample. Journal of Reproductive and Infant Psychology. ahead-of-print:1-20. 2023
- Loss of age-related laminar differentiation of intracortical myelin in bipolar disorder. Cerebral Cortex. 33:7468-7476. 2023
- Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study. Scientific Reports. 13:8418. 2023
- 286. Genetic Polymorphism of Brain-Derived Neurotrophic Factor is Related to Antidepressant Efficacy and Treatment-Induced Hippocampal Plasticity in Patients With Major Depressive Disorder: CAN-BIND-1 Study. Biological Psychiatry. 93:S209-S209. 2023
- Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder. Canadian Journal of Psychiatry. 68:299-311. 2023
- Triggers for acute mood episodes in bipolar disorder: A systematic review. Journal of Psychiatric Research. 161:237-260. 2023
- Biological rhythms disruption mediates the association between mother's diagnosis of bipolar disorder and offspring's emotional/behavioral problems. Journal of Affective Disorders. 327:230-235. 2023
- Functional assessment short test (FAST): Self-administration in outpatient mental health settings. Journal of Psychiatric Research. 160:258-262. 2023
- Predictors of perceived symptom change with acute cannabis use for mental health conditions in a naturalistic sample: A machine learning approach. Comprehensive Psychiatry. 122:152377-152377. 2023
- Lifestyle Behaviors, Depression, and Anxiety Among Individuals Living in Canada During the COVID-19 Pandemic. American Journal of Lifestyle Medicine. 17:181-193. 2023
- Cerebello-cerebral Functional Connectivity Networks in Major Depressive Disorder: a CAN-BIND-1 Study Report. Cerebellum. 22:26-36. 2023
- Chronobiological parameters as predictors of early treatment response in major depression. Journal of Affective Disorders. 323:679-688. 2023
- Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A Canadian Biomarker Integration Network for Depression Study. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 8:162-170. 2023
- AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale. BMC Psychiatry. 23:59. 2023
- Gray matter volume drives the brain age gap in schizophrenia: a SHAP study. Schizophrenia (Heidelb). 9:3. 2023
- The pharmacotherapeutic management of premenstrual dysphoric disorder. Expert Opinion on Pharmacotherapy. 24:145-151. 2023
- A tale of two targets: examining the differential effects of posterior cingulate cortex- and amygdala-targeted fMRI-neurofeedback in a PTSD pilot study. Frontiers in Neuroscience. 17:1229729. 2023
- Estradiol Replacement as a Potential Enhancer of Working Memory and Neuroplasticity in Hypogonadal Trans Women. Neuroendocrinology. 113:489-500. 2023
- Rasch analyses of the Quick Inventory of Depressive Symptomatology Self-Report in neurodegenerative and major depressive disorders. Frontiers in Psychiatry. 14:1154519. 2023
- The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. Canadian Journal of Psychiatry. 68:5-21. 2023
- Visual QC Protocol for FreeSurfer Cortical Parcellations from Anatomical MRI. Aperture Neuro. 2022
- Alterations in the neural correlates of affective inhibitory control following cognitive behavioral therapy for depression: A Canadian biomarker integration network for depression (CAN-BIND) study. Journal of Affective Disorders Reports. 10:100413-100413. 2022
- An investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample. BMC Psychiatry. 22:303. 2022
- The PPD-ACT app in Canada: feasibility and a latent class analysis of participants with postpartum depression recruited to a psychiatric genetics study using a mobile application. BMC Psychiatry. 22:735. 2022
- Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study. Pharmacopsychiatry. 55:297-303. 2022
- Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study. Translational Psychiatry. 12:366. 2022
- Acute and chronic stress predict anti-depressant treatment outcome and naturalistic course of major depression: A CAN-BIND report. Journal of Affective Disorders. 313:8-14. 2022
- “One Degree of Separation”: A Mixed-Methods Evaluation of Canadian Mental Health Care User and Provider Experiences With Remote Care During COVID-19. Canadian Journal of Psychiatry. 67:712-722. 2022
- Impact of the CBT-Meno protocol on menopause-specific beliefs, dysfunctional attitudes, and coping behaviors. Menopause. 29:963-972. 2022
- Network properties of intracortical myelin associated with psychosocial functioning in bipolar I disorder. Bipolar Disorders. 24:539-548. 2022
- Decreased Expression of Cerebral Dopamine Neurotrophic Factor in Platelets of Probable Alzheimer Patients. Alzheimer Disease and Associated Disorders. 36:269-271. 2022
- Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs. European Neuropsychopharmacology. 60:91-99. 2022
- Intolerance of Uncertainty and Perfectionistic Beliefs About Parenting as Cognitive Mechanisms of Symptom Change During Cognitive Behavior Therapy for Perinatal Anxiety. Behavior Therapy. 53:738-750. 2022
- Investigation of blood-brain barrier disruption in an animal model of mania induced by D-amphetamine. Journal of Affective Disorders Reports. 9:100368-100368. 2022
- Rhythmicity of sleep and clinical outcomes in major depressive disorder: A CAN-BIND-1 report. Journal of Affective Disorders Reports. 9:100370-100370. 2022
- Validation and psychometric properties of the Spanish Mood Rhythm Instrument. Biological Rhythm Research. 53:841-853. 2022
- Conversion to major neurocognitive disorder after COVID‐19 in a woman with bipolar disorder: A 6‐year longitudinal case report. Bipolar Disorders. 24:451-456. 2022
- Pain severity and pain interference during major depressive episodes treated with escitalopram and aripiprazole adjunctive therapy: a CAN-BIND-1 report. Psychiatry Research. 312:114557-114557. 2022
- The relationship between parental bonding and mood, anxiety and related disorders in adulthood: A systematic review and meta-analysis. Journal of Affective Disorders. 307:221-236. 2022
- Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial. Translational Psychiatry. 12:214. 2022
- AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale 2022
- Characterizing worry content and impact in pregnant and postpartum women with anxiety disorders during COVID‐19. Clinical Psychology and Psychotherapy. 29:1144-1157. 2022
- Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report. Journal of Psychopharmacology. 36:604-613. 2022
- Neurobiological and behavioral mechanisms of circadian rhythm disruption in bipolar disorder: A critical multi‐disciplinary literature review and agenda for future research from the ISBD task force on chronobiology. Bipolar Disorders. 24:232-263. 2022
- P11. Predictors of Illicit Substance Abuse/Dependence During Young Adulthood: A Machine Learning Approach. Biological Psychiatry. 91:S91-S92. 2022
- P252. Passive Behavior Sensing Features and Depression Characteristics in a Prospective Relapse Monitoring Study. Biological Psychiatry. 91:S189-S189. 2022
- P382. Replication of Personalized Relapse Prediction in Patients With Major Depressive Disorder Using Digital Biomarkers. Biological Psychiatry. 91:S241-S242. 2022
- Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy. Brain and Behavior. 12:e2555. 2022
- The prevalence of borderline personality features and borderline personality disorder during the perinatal period: a systematic review and meta-analysis. Archives of Women's Mental Health. 25:277-289. 2022
- A DSM-5-based tool to monitor concurrent mood and premenstrual symptoms: the McMaster Premenstrual and Mood Symptom Scale (MAC-PMSS). BMC Women's Health. 22:96. 2022
- Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial. Translational Psychiatry. 12:101. 2022
- Biophysical compartment models for single-shell diffusion MRI in the human brain: a model fitting comparison. Physics in Medicine and Biology. 67:055009-055009. 2022
- Baseline Functional Connectivity in Resting State Networks Associated with Depression and Remission Status after 16 Weeks of Pharmacotherapy: A CAN-BIND Report. Cerebral Cortex. 32:1223-1243. 2022
- Depression in midlife women attending a menopause clinic is associated with a history of childhood maltreatment. Climacteric. 25:203-207. 2022
- Baseline anxiety, and early anxiety/depression improvement in anxious depression predicts treatment outcomes with escitalopram: A CAN-BIND-1 study report. Journal of Affective Disorders. 300:50-58. 2022
- Investigating the relationship between objective measures of sleep and self-report sleep quality in healthy adults: a review. Journal of Clinical Sleep Medicine. 18:927-936. 2022
- Longitudinal Changes in Sleep, Biological Rhythms, and Light Exposure From Late Pregnancy to Postpartum and Their Impact on Peripartum Mood and Anxiety. Journal of Clinical Psychiatry. 83:21m13991. 2022
- A detailed manual segmentation procedure for the hypothalamus for 3T T1-weighted MRI. MethodsX. 9:101864-101864. 2022
- Adaptation and validation of the Mood Rhythm Instrument for use in Brazilian adolescents. Revista Brasileira de Psiquiatria. 44:264-270. 2022
- Brain age in mood and psychotic disorders: a systematic review and meta‐analysis. Acta Psychiatrica Scandinavica. 145:42-55. 2022
- Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders. Frontiers in Psychiatry. 13:816465. 2022
- Effective recommendations towards healthy routines to preserve mental health during the COVID-19 pandemic. Revista Brasileira de Psiquiatria. 44:136-146. 2022
- Lifestyle predictors of depression and anxiety during COVID-19: a machine learning approach. Trends in Psychiatry and Psychotherapy. 44:e20210365. 2022
- Melatonin use during pregnancy and lactation: A scoping review of human studies. Revista Brasileira de Psiquiatria. 44:342-348. 2022
- Physician suicide demographics and the COVID-19 pandemic. Revista Brasileira de Psiquiatria. 44:124-135. 2022
- Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report. NeuroImage: Clinical. 35:103120-103120. 2022
- Evaluation of an Augmented Cognitive Behavioural Group Therapy for Perinatal Generalized Anxiety Disorder (GAD) during the COVID-19 Pandemic. Journal of Clinical Medicine. 11:209-209. 2021
- 5-year incidence of suicide-risk in youth: A gradient tree boosting and SHAP study. Journal of Affective Disorders. 295:1049-1056. 2021
- Association between discrepancy in objective and subjective cognitive abilities and treatment response in patients with major depressive disorder: A CAN-BIND-1 study report. Journal of Affective Disorders. 295:1095-1101. 2021
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations. Bipolar Disorders. 23:767-788. 2021
- Machine learning in the prediction of depression treatment outcomes: a systematic review and meta-analysis. Psychological Medicine. 51:2742-2751. 2021
- Structural covariance pattern abnormalities of insula in major depressive disorder: A CAN-BIND study report. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 111:110194-110194. 2021
- Suicidal Risk in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Systematic Review and Meta-Analysis. Journal of Women's Health. 30:1693-1707. 2021
- The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder. Canadian Journal of Psychiatry. 66:1102-1102. 2021
- Validation of the intolerance of uncertainty scale as a screening tool for perinatal anxiety. BMC Pregnancy and Childbirth. 21:829. 2021
- Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force. Bipolar Disorders. 23:659-678. 2021
- Interactions between neuroticism and stressful life events predict response to pharmacotherapy for major depression: A CAN‐BIND 1 report. Personality and Mental Health. 15:273-282. 2021
- The Use of Cannabinoids for Insomnia in Daily Life: Naturalistic Study. Journal of Medical Internet Research. 23:e25730-e25730. 2021
-
Exploring brain connectivity changes in major depressive disorder using
functional‐structural data fusion: A CAN‐BIND‐1 study. Human Brain Mapping. 42:4940-4957. 2021 - Investigation of Blood-Brain Barrier Disruption in an Animal Model of Mania Induced by d-Amphetamine 2021
- Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study report. Psychoneuroendocrinology. 132:105348-105348. 2021
- Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report. Translational Psychiatry. 11:469. 2021
- Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Professionnel Durant Le Traitement Par Escitalopram Chez Des Patients Souffrant De Trouble Dépressif Majeur: Une Étude Can-Bind-1. Canadian Journal of Psychiatry. 66:798-806. 2021
- Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report. Pharmacopsychiatry. 54:225-231. 2021
- Risk factors for new-onset bipolar disorder in a community cohort: A five-year follow up study. Psychiatry Research. 303:114109-114109. 2021
- The role of emotion dysregulation in cognitive behavioural group therapy for perinatal anxiety: Results from a randomized controlled trial and routine clinical care. Journal of Affective Disorders. 292:517-525. 2021
- Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response. Translational Psychiatry. 11:439. 2021
- Sleep, biological rhythms and anxiety in the perinatal period: a systematic review protocol. BMJ Open. 11:e046767-e046767. 2021
- Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report. Communications Biology. 4:903. 2021
- Cognitive Behavior Therapy for Women With Generalized Anxiety Disorder in the Perinatal Period: Impact on Problematic Behaviors. Behavior Therapy. 52:907-916. 2021
- Preliminary insights into the genetic architecture of postpartum depressive symptom severity using polygenic risk scores. Personalized Medicine in Psychiatry. 27-28:100081-100081. 2021
- Cognitive complaints in individuals recently diagnosed with bipolar disorder: A cross-sectional study. Psychiatry Research. 300:113894-113894. 2021
- White matter microstructure in youth at risk for serious mental illness: A comparative analysis. Psychiatry Research - Neuroimaging. 312:111289-111289. 2021
- Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report. CNS Drugs. 35:439-450. 2021
- Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report. CNS Drugs. 35:291-304. 2021
- Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response. Translational Psychiatry. 11:127. 2021
- Novel mechanism of action for the mood stabilizer lithium. Bipolar Disorders. 23:76-83. 2021
- The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L’humeur Et De L’anxiété (Canmat) Concernant L’utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur. Canadian Journal of Psychiatry. 66:113-125. 2021
- The Revised Mood Rhythm Instrument: A Large Multicultural Psychometric Study. Journal of Clinical Medicine. 10:388-388. 2021
- Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report. NeuroImage: Clinical. 32:102864-102864. 2021
- Comorbid Premenstrual Dysphoric Disorder and Bipolar Disorder: A Review. Frontiers in Psychiatry. 12:719241. 2021
- Magnetic Resonance Imaging Sequence Identification Using a Metadata Learning Approach. Frontiers in Neuroinformatics. 15:622951. 2021
- Multisite Comparison of MRI Defacing Software Across Multiple Cohorts. Frontiers in Psychiatry. 12:617997. 2021
- Predicting Brain Age at Slice Level: Convolutional Neural Networks and Consequences for Interpretability. Frontiers in Psychiatry. 12:598518. 2021
- Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1. PLoS ONE. 16:e0253023-e0253023. 2021
- Neural correlates of verbal recognition memory in obese adults with and without major depressive disorder. Brain and Behavior. 10:e01848. 2020
- Quality assurance assessment of a specialized perinatal mental health clinic. BMC Pregnancy and Childbirth. 20:485. 2020
- Validation of the English version of the Mood Rhythm Instrument. BMC Psychology. 8:35. 2020
- The Use of Cannabinoids for Insomnia in Daily Life: Naturalistic Study (Preprint) 2020
- Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report. Psychological Medicine. 50:2536-2547. 2020
- Measuring circadian function in bipolar disorders: Empirical and conceptual review of physiological, actigraphic, and self‐report approaches. Bipolar Disorders. 22:693-710. 2020
- The Early Burden of Disability in Individuals With Mood and Other Common Mental Disorders in Ontario, Canada. JAMA network open. 3:e2020213-e2020213. 2020
- The PPD-ACT App: Feasibility of a mobile application for recruiting women with postpartum depression and psychosis to a psychiatric genetics study (Preprint) 2020
- Objective and subjective vasomotor symptom outcomes in the CBT-Meno randomized controlled trial. Climacteric. 23:482-488. 2020
- Lifetime cocaine use is a potential predictor for conversion from major depressive disorder to bipolar disorder: A prospective study. Psychiatry and Clinical Neurosciences. 74:418-423. 2020
- Preeclampsia as a risk factor for postpartum depression and psychosis: a systematic review and meta-analysis. Archives of Women's Mental Health. 23:493-505. 2020
- Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report. Neuropsychopharmacology. 45:1390-1397. 2020
- THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial.. Innovations in Clinical Neuroscience. 17:30-40. 2020
- Toward prevention of bipolar disorder in at-risk children: Potential strategies ahead of the data. Journal of Affective Disorders. 272:508-520. 2020
- Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder. Journal of Clinical Psychiatry. 81:20m13229. 2020
- Reliability of a functional magnetic resonance imaging task of emotional conflict in healthy participants. Human Brain Mapping. 41:1400-1415. 2020
- Cognitive behavioral therapy for perinatal anxiety: A randomized controlled trial. Australian and New Zealand Journal of Psychiatry. 54:423-432. 2020
- Differential biomarker signatures in unipolar and bipolar depression: A machine learning approach. Australian and New Zealand Journal of Psychiatry. 54:393-401. 2020
- Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report. International Journal of Neuropsychopharmacology. 23:88-95. 2020
- Emotional reactivity and explicit emotional memory biases in major depressive disorder during euthymia. Psychiatry Research. 285:112847-112847. 2020
- Escitalopram ameliorates differences in neural activity between healthy comparison and major depressive disorder groups on an fMRI Emotional conflict task: A CAN-BIND-1 study. Journal of Affective Disorders. 264:414-424. 2020
- Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkers. Journal of Affective Disorders. 263:353-366. 2020
- Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression. JAMA network open. 3:e1918377-e1918377. 2020
- An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report. NeuroImage: Clinical. 25:102178-102178. 2020
- Decreased Expression of Cerebral Dopamine Neurotrophic Factor in Platelets of Stroke Patients. Journal of Stroke and Cerebrovascular Diseases. 29:104502-104502. 2020
- Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report. Neuropsychopharmacology. 45:283-291. 2020
- Structural and Functional Brain Correlates of Neuroprogression in Bipolar Disorder. Current Topics in Behavioral Neurosciences. 48:197-213. 2020
- The Link between Estradiol and Neuroplasticity in Transgender Women after Gender-Affirming Surgery: A Bimodal Hypothesis. Neuroendocrinology. 110:489-500. 2020
- Understanding the complex interplay between violence, depression and suicidal ideation in women: Time for a comprehensive sex- and gender-based approach. Revista Brasileira de Psiquiatria. 42:467-468. 2020
- Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants. Translational Psychiatry. 9:254. 2019
- Reduced accuracy accompanied by reduced neural activity during the performance of an emotional conflict task by unmedicated patients with major depression: A CAN-BIND fMRI study. Journal of Affective Disorders. 257:765-773. 2019
- White Matter Indices of Medication Response in Major Depression: A Diffusion Tensor Imaging Study. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 4:913-924. 2019
- Cognitive behavior therapy for menopausal symptoms (CBT-Meno): a randomized controlled trial. Menopause. 26:972-980. 2019
- Cognitive behavior therapy for menopausal symptoms (CBT-Meno): a randomized controlled trial.. Menopause. 26:972-980. 2019
- Effort-based decision-making is affected by overweight/obesity in major depressive disorder. Journal of Affective Disorders. 256:221-227. 2019
- Explicit emotional memory biases in mood disorders: A systematic review. Psychiatry Research. 278:162-172. 2019
- Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participants. NeuroImage. 197:589-597. 2019
- The use of cannabinoids for sleep: A critical review on clinical trials.. Experimental and Clinical Psychopharmacology. 27:383-401. 2019
- Association of functioning and quality of life with objective and subjective measures of sleep and biological rhythms in major depressive and bipolar disorder. Australian and New Zealand Journal of Psychiatry. 53:683-696. 2019
- Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report. Psychological Medicine. 49:1629-1638. 2019
- The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols. Journal of Psychiatry & Neuroscience. 44:223-236. 2019
- Inter-rater reliability of DartfishTM movement analysis software for measuring maximum flexion and extension at the hip and knee in older adults with osteoporosis and osteopenia. Psychological Medicine. 35:577-585. 2019
- Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment. Journal of Clinical Psychiatry. 80:18m12556. 2019
- Biological and psychosocial predictors of anxiety worsening in the postpartum period: A longitudinal study. Journal of Affective Disorders. 250:218-225. 2019
- Impact of a structured, group-based running programme on clinical, cognitive and social function in youth and adults with complex mood disorders: a 12-week pilot study. BMJ Open Sport and Exercise Medicine. 5:e000521-e000521. 2019
- OR25-4 Modulatory Effects of Estradiol on the Resting-State Functional Connectivity in Transwomen Following Gender Affirming Surgery. Journal of the Endocrine Society. 3:or25-or24. 2019
- Adjunctive tianeptine treatment for bipolar disorder: A 24-week randomized, placebo-controlled, maintenance trial. Journal of Psychopharmacology. 33:502-510. 2019
- Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review. Alcoholism: Clinical and Experimental Research. 43:550-563. 2019
- Cerebral cortical thickness after treatment with desvenlafaxine succinate in major depressive disorder. NeuroReport. 30:378-382. 2019
- Age-related deficits in intracortical myelination in young adults with bipolar disorder type I. Journal of Psychiatry & Neuroscience. 44:79-88. 2019
- Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder. Journal of Clinical Psychiatry. 80:18m12202. 2019
- Altered hippocampal function with preserved cognitive performance in treatment-naive major depressive disorder. NeuroReport. 30:46-52. 2019
- Cortical thickness in major depressive disorder: A systematic review and meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 88:287-302. 2019
- Effects of Estradiol Therapy on Resting-State Functional Connectivity of Transgender Women After Gender-Affirming Related Gonadectomy. Frontiers in Neuroscience. 13:817. 2019
- From anatomy to function: the role of the somatosensory cortex in emotional regulation. Revista Brasileira de Psiquiatria. 41:261-269. 2019
- A longitudinal study of neurotrophic, oxidative, and inflammatory markers in first-onset depression in midlife women. European Archives of Psychiatry and Clinical Neuroscience. 268:771-781. 2018
- Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project. Australian and New Zealand Journal of Psychiatry. 52:1173-1182. 2018
- Structural and functional changes in the somatosensory cortex in euthymic females with bipolar disorder. Australian and New Zealand Journal of Psychiatry. 52:1075-1083. 2018
- Non-pharmacological interventions for improving postpartum maternal sleep: A systematic review and meta-analysis. Sleep Medicine Reviews. 41:87-100. 2018
- Risk factors of new onset anxiety and anxiety exacerbation in the perinatal period: A systematic review and meta-analysis. Journal of Affective Disorders. 238:626-635. 2018
- The Menopause Visual Analogue Scale: a new tool for measuring the severity and response to treatment of symptoms throughout the menopausal transition. Climacteric. 21:502-508. 2018
- Resting-state functional connectivity in individuals with bipolar disorder during clinical remission: a systematic review. Journal of Psychiatry & Neuroscience. 43:298-316. 2018
- The Role of Circadian Rhythms in Postpartum Sleep and Mood. Sleep Medicine Clinics. 13:359-374. 2018
- Resting-state functional connectivity in individuals with bipolar disorder during clinical remission: a systematic review.. Journal of Psychiatry & Neuroscience. 43:298-316. 2018
- Rhythmicity of Mood Symptoms in Individuals at Risk for Psychiatric Disorders. Scientific Reports. 8:11402. 2018
- Association of intracortical myelin and cognitive function in bipolar I disorder. Acta Psychiatrica Scandinavica. 138:62-72. 2018
- Effects of a 12-week running programme in youth and adults with complex mood disorders. BMJ Open Sport and Exercise Medicine. 4:e000314-e000314. 2018
-
Canadian Network for Mood and Anxiety Treatments (
CANMAT ) and International Society for Bipolar Disorders (ISBD ) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders. 20:97-170. 2018 - The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study. Journal of Affective Disorders. 227:542-549. 2018
- Performance of the biological rhythms interview for assessment in neuropsychiatry: An item response theory and actigraphy analysis. Journal of Affective Disorders. 225:54-63. 2018
- Prospective Assessment of Daily Patterns of Mood-Related Symptoms. Frontiers in Psychiatry. 9:370. 2018
- Volumetric MRI Analysis of a Case of Severe Ventriculomegaly. Frontiers in Human Neuroscience. 12:495. 2018
- Salivary cortisol during memory encoding in pregnancy predicts postpartum depressive symptoms: a longitudinal study. Trends in Psychiatry and Psychotherapy. 39:280-284. 2017
- Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Archives of Women's Mental Health. 20:713-719. 2017
- Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP‐BD study. Acta Psychiatrica Scandinavica. 136:473-482. 2017
- Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression. Scientific Reports. 7:7473. 2017
- Altered intracortical myelin staining in the dorsolateral prefrontal cortex in severe mental illness. European Archives of Psychiatry and Clinical Neuroscience. 267:369-376. 2017
- Age‐related mapping of intracortical myelin from late adolescence to middle adulthood using T1‐weighted MRI. Human Brain Mapping. 38:3691-3703. 2017
- MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes. Nature Communications. 8:15497. 2017
- A statistical method to calculate blood contamination in the measurement of salivary hormones in healthy women. Clinical Biochemistry. 50:436-439. 2017
- Influence of endogenous estradiol, progesterone, allopregnanolone, and dehydroepiandrosterone sulfate on brain resting state functional connectivity across the menstrual cycle. Fertility and Sterility. 107:1246-1255.e4. 2017
- O-GYN-MD-054 Cognitive Behaviour Therapy for Menopausal Symptoms (CBT-MENO): Preliminary Results from a Randomized Controlled Trial (RCT) – A Mid-Way, Interim Analysis. Journal of Obstetrics and Gynaecology Canada. 39:388-388. 2017
- Resting state functional connectivity in women with bipolar disorder during clinical remission. Bipolar Disorders. 19:97-106. 2017
- Subtle persistent working memory and selective attention deficits in women with premenstrual syndrome. Psychiatry Research. 249:354-362. 2017
- Convergent lines of evidence support the role of uric acid levels as a potential biomarker in bipolar disorder. Expert Review of Molecular Diagnostics. 17:107-108. 2017
- Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression. Scientific Reports. 7:41382. 2017
- Brain Structure and Function in Women with Comorbid Bipolar and Premenstrual Dysphoric Disorder. Frontiers in Psychiatry. 8:301. 2017
- The impact of obesity on neuropsychological functioning in adults with and without major depressive disorder. PLoS ONE. 12:e0176898-e0176898. 2017
- Validation of the Brazilian Portuguese version of the Premenstrual Symptoms Screening Tool (PSST) and association of PSST scores with health-related quality of life. Revista Brasileira de Psiquiatria. 39:140-146. 2017
- Biological rhythms are independently associated with quality of life in bipolar disorder. International Journal of Bipolar Disorders. 4:9. 2016
- Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort. BMC Psychiatry. 16:105. 2016
-
RNA ‐sequencing profiles hippocampal gene expression in a validated model of cancer‐induced depression. Genes, Brain and Behavior. 15:711-721. 2016 - Update on bipolar disorder biomarker candidates. Expert Review of Molecular Diagnostics. 16:1209-1220. 2016
- Biological rhythms, metabolic syndrome and current depressive episode in a community sample. Psychoneuroendocrinology. 72:34-39. 2016
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder. Canadian Journal of Psychiatry. 61:588-603. 2016
- Relationship between inflammatory biomarkers and depressive symptoms during late pregnancy and the early postpartum period: a longitudinal study. Revista Brasileira de Psiquiatria. 38:190-196. 2016
- Sleep, daily activity rhythms and postpartum mood: A longitudinal study across the perinatal period. Chronobiology International. 33:791-801. 2016
- Do changes in subjective sleep and biological rhythms predict worsening in postpartum depressive symptoms? A prospective study across the perinatal period. Archives of Women's Mental Health. 19:591-598. 2016
- Mild Depressive Symptoms During the Third Trimester of Pregnancy Are Associated with Disruptions in Daily Rhythms but Not Subjective Sleep Quality. Journal of Women's Health. 25:594-598. 2016
- The Mood Rhythm Instrument: development and preliminary report. Revista Brasileira de Psiquiatria. 38:148-153. 2016
- Treating comorbid premenstrual dysphoric disorder in women with bipolar disorder. Journal of Psychiatry & Neuroscience. 41:E22-E23. 2016
- Effect of obesity on cognition in adults with and without a mood disorder: study design and methods. BMJ Open. 6:e009347-e009347. 2016
- The association between biological rhythms, depression, and functioning in bipolar disorder: a large multi‐center study. Acta Psychiatrica Scandinavica. 133:102-108. 2016
- The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive Disorder.. Innovations in Clinical Neuroscience. 13:20-31. 2016
- Effects of Oral Contraceptive Pills on Mood: Lessons Learned from Longitudinal Studies. Canadian Journal of Diabetes. 39:536-536. 2015
- Depressive-like behaviours and decreased dendritic branching in the medial prefrontal cortex of mice with tumors: A novel validated model of cancer-induced depression. Behavioural Brain Research. 294:25-35. 2015
- Emotional memory in pregnant women at risk for postpartum depression. Psychiatry Research. 229:777-783. 2015
- Cognitive-behavioral group treatment for perinatal anxiety: a pilot study. Archives of Women's Mental Health. 18:631-638. 2015
- Assessing intracortical myelin in the living human brain using myelinated cortical thickness. Frontiers in Neuroscience. 9:396. 2015
- Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?. Neural Plasticity. 2015:1-12. 2015
- Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal Cord. PLoS ONE. 10:e0142598-e0142598. 2015
- Translational Research in Bipolar Disorders. Neural Plasticity. 2015:1-3. 2015
- Comparative Efficacy of the Generalized Anxiety Disorder 7-Item Scale and the Edinburgh Postnatal Depression Scale as Screening Tools for Generalized Anxiety Disorder in Pregnancy and the Postpartum Period. Canadian Journal of Psychiatry. 59:434-440. 2014
- Alterations in circadian rhythms are associated with increased lipid peroxidation in females with bipolar disorder. International Journal of Neuropsychopharmacology. 17:715-722. 2014
- Val66Met polymorphism and serum brain‐derived neurotrophic factor in bipolar disorder: an open‐label trial. Acta Psychiatrica Scandinavica. 129:393-400. 2014
- Sex hormones and biomarkers of neuroprotection and neurodegeneration: implications for female reproductive events in bipolar disorder. Bipolar Disorders. 16:48-57. 2014
- Changes in cortical thickness across the lifespan in major depressive disorder. Psychiatry Research. 214:204-211. 2013
- New-onset psychosis following androgen deprivation therapy for prostate cancer.. Canadian Journal of Urology. 20:6868-6870. 2013
- Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated Bipolar Disorder Guidelines. Bipolar Disorders. 15:338-339. 2013
- Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Australian and New Zealand Journal of Psychiatry. 47:321-332. 2013
- A primary care-based treatment programme improves postpartum depression at 12 months. Evidence-Based Mental Health. 16:6-6. 2013
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorders. 15:1-44. 2013
- Comorbid bipolar disorder and premenstrual dysphoric disorder: real patients, unanswered questions. Archives of Women's Mental Health. 16:79-81. 2013
- Effects of quetiapine extended release on sleep and quality of life in midlife women with major depressive disorder. Archives of Women's Mental Health. 16:83-85. 2013
- Soft Bipolar Spectrum and Staging in Bipolar Disorder. Current Psychiatry Research and Reviews. 9:33-40. 2013
- The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future. Bipolar Disorders. 15:58-60. 2013
- The Clinical Implications Of Cognitive Impairment and Allostatic Load in Bipolar Disorder. European psychiatry. 28:21-29. 2013
- Sensitivity and Specificity of the Mood Disorder Questionnaire as a Screening Tool for Bipolar Disorder During Pregnancy and the Postpartum Period. Journal of Clinical Psychiatry. 73:1456-1461. 2012
- Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: An open-label trial in drug-free patients with bipolar disorder. Journal of Psychiatric Research. 46:1511-1514. 2012
- Increased cerebral oxidative damage and decreased antioxidant defenses in ovariectomized and sham-operated rats supplemented with vitamin A. Cell Biology and Toxicology. 28:317-330. 2012
- Depression During the Menopausal Transition: An Update on Epidemiology and Biological Treatments. Focus: The Journal of Lifelong Learning in Psychiatry. 10:22-27. 2012
- P-179 - Brain-derived neurotrophic factor as a biomarker of clinical response in bipolar disorder: 16 week follow-up study. European psychiatry. 27:1-1. 2012
- Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder. Oxidative Medicine and Cellular Longevity. 2012:1-13. 2012
- Depression in Women. Journal of Clinical Psychiatry. 72:e1563-e1569. 2011
- Sleep and Circadian Rhythm Disturbances in Bipolar Disorder. Journal of Clinical Psychiatry. 72:724-724. 2011
- Non-Hormonal Treatment Strategies for Vasomotor Symptoms. Drugs. 71:287-304. 2011
- An investigation of the impact of weight loss on cognition in adults with Bipolar Disorder and Major Depressive Disorder. Canadian Journal of Diabetes. 35:215-215. 2011
- Mitochondrial Dysfunction in Bipolar Disorder: Lessons from Brain Imaging and Molecular Markers. Revista Colombiana de Psiquiatria. 40:166S-182S. 2011
- Is there a role for estrogen in treating depression during menopause?. Journal of Psychiatry & Neuroscience. 35:E6-E7. 2010
- A Pilot, 8-Week, Placebo Lead-In Trial of Quetiapine Extended Release for Depression in Midlife Women. Journal of Clinical Psychopharmacology. 30:612-615. 2010
- The rapid effects of estrogen: a mini-review. Behavioural Pharmacology. 21:465-472. 2010
- Gender differences in α-[11C]MTrp brain trapping, an index of serotonin synthesis, in medication-free individuals with major depressive disorder: A positron emission tomography study. Psychiatry Research. 183:157-166. 2010
- Shift in the brain network of emotional regulation in midlife women. Menopause. 17:840-845. 2010
- Approach to Premenstrual Dysphoria for the Mental Health Practitioner. Psychiatric Clinics of North America. 33:257-272. 2010
- Challenges and Opportunities to Manage Depression During the Menopausal Transition and Beyond. Psychiatric Clinics of North America. 33:295-308. 2010
- Plasma Brain-Derived-Neurotrophic Factor levels and cognitive function in euthymic bipolar type I patients. Annals of General Psychiatry. 9:s218. 2010
- Cognitive function and serum levels of brain‐derived neurotrophic factor in patients with bipolar disorder. Bipolar Disorders. 11:663-671. 2009
- Clinical implications of a staging model for bipolar disorders. Expert Review of Neurotherapeutics. 9:957-966. 2009
- Neuronal Correlates of Brain-derived Neurotrophic Factor Val66Met Polymorphism and Morphometric Abnormalities in Bipolar Disorder. Neuropsychopharmacology. 34:1904-1913. 2009
- Marcadores de estrés oxidativo en el trastorno bipolar: un metaanálisis. Psiquiatria Biologica. 16:60-69. 2009
- Early intervention in bipolar disorders: Clinical, biochemical and neuroimaging imperatives. Journal of Affective Disorders. 114:1-13. 2009
- Brain‐derived neurotrophic factor in bipolar disorder: beyond trait and state: comment on ‘Decreased levels of serum brain‐derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders’. Bipolar Disorders. 11:221-222. 2009
- Advances in the Pathophysiology of Episode-Related Cognitive Impairment in Bipolar Disorder. European psychiatry. 24:s14. 2009
- Electrophysiological correlates of sleep disturbance induced by acute and chronic administration of d-amphetamine. Brain Research. 1249:162-172. 2009
- Gender Differences in Brain Serotonin Synthesis in Individuals with Major Depressive Disorder: A A-[11C]MT Pet Imaging Study. European psychiatry. 24:s681. 2009
- Managing Depression and Anxiety during the Menopausal Transition and Beyond: The Window of Vulnerability. Key Issues in Mental Health. 175:102-114. 2009
- Midlife Women with Major Depressive Disorder: Effects of Quetiapine Extended-release on Mood, Sleep and Menopause-related Symptoms. European psychiatry. 24:s680. 2009
- Increased oxidative stress as a mechanism for the decreased levels of BDNF in acute manic episodes (vol 30, pg 243, 2008). Revista Brasileira de Psiquiatria. 30:432-432. 2008
- Oxidative stress markers in bipolar disorder: A meta-analysis. Journal of Affective Disorders. 111:135-144. 2008
- Corrected values of brain metabolites for the article: ‘Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication‐free individuals with bipolar disorder: an in vivo1H MRS study’. Bipolar Disorders. 10:849-849. 2008
- Effects of mood stabilizers on DNA damage in an animal model of mania.. Journal of Psychiatry & Neuroscience. 33:516-524. 2008
- Illness duration and total brain gray matter in bipolar disorder: Evidence for neurodegeneration?. European Neuropsychopharmacology. 18:717-722. 2008
- Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates. Post Reproductive Health. 14:123-128. 2008
- Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Revista Brasileira de Psiquiatria. 30:243-245. 2008
- Insight, quality of life and cognitive functioning in euthymic patients with bipolar disorder. Journal of Affective Disorders. 110:75-83. 2008
- Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience. 258:300-304. 2008
- Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Review of Neurotherapeutics. 8:1101-1113. 2008
- Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania. Journal of Psychiatric Research. 42:416-421. 2008
- Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double‐blind, randomized, placebo‐controlled study. Human Psychopharmacology. 23:87-94. 2008
- Allostatic load in bipolar disorder: Implications for pathophysiology and treatment. Neuroscience and Biobehavioral Reviews. 32:675-692. 2008
- Mismatch between self-reported quality of life and functional assessment in acute mania: A matter of unawareness of illness?. Journal of Affective Disorders. 103:247-252. 2007
- Brain-derived neurotrophic factor val66met polymorphism affects prefrontal energy metabolism in bipolar disorder. NeuroReport. 18:1567-1570. 2007
- DNA damage in bipolar disorder. Psychiatry Research. 153:27-32. 2007
- Manic symptoms and quality of life in bipolar disorder. Psychiatry Research. 153:33-38. 2007
- The role of hippocampus in the pathophysiology of bipolar disorder. Behavioural Pharmacology. 18:419-430. 2007
- DNA damage in rats after treatment with methylphenidate. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31:1282-1288. 2007
- Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication‐free individuals with bipolar disorder: an in vivo1H MRS study. Bipolar Disorders. 9:119-127. 2007
- Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats. Behavioural Pharmacology. 18:205-212. 2007
- Anxiety Comorbidity and Quality of Life in Bipolar Disorder Patients. Canadian Journal of Psychiatry. 52:175-181. 2007
- Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neuroscience Letters. 415:87-89. 2007
- Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder. Molecular Psychiatry. 12:230-231. 2007
- Fluvoxamina no transtorno depressivo maior: um estudo multicêntrico aberto. Jornal Brasileiro de Psiquiatria. 56:17-22. 2007
- Increased oxidative stress and DNA damage in bipolar disorder: A twin-case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31:283-285. 2007
- Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neuroscience Letters. 407:146-150. 2006
- Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.. Journal of Psychiatry & Neuroscience. 31:326-332. 2006
- Evidence of astrogliosis in rat hippocampus after d-amphetamine exposure. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30:1231-1234. 2006
- Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sciences. 79:281-286. 2006
- Glial fibrillary acidic protein expression after electroconvulsive shocks in rat brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30:663-667. 2006
- Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disorders. 8:275-280. 2006
- Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Research. 1097:224-229. 2006
- Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania. Behavioural Pharmacology. 17:311-318. 2006
- Changes in Antioxidant Defense Enzymes after d-amphetamine Exposure: Implications as an Animal Model of Mania. Neurochemical Research. 31:699-703. 2006
- Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neuroscience Letters. 398:215-219. 2006
- Pharmacological treatment of bipolar disorder: Evidence from randomized clinical trials. Revista de Psiquiatria Clinica. 32:34-38. 2005
- A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania. Human Psychopharmacology. 20:133-139. 2005
- Neurobiological basis of bipolar disorder. Revista de Psiquiatria Clinica. 32:28-33. 2005
- Fisiopatologia do transtorno afetivo bipolar: o que mudou nos últimos 10 anos?. Revista Brasileira de Psiquiatria. 26:17-21. 2004
- Anormalidades neuropatológicas e neuroquímicas no transtorno afetivo bipolar. Revista Brasileira de Psiquiatria. 26:180-188. 2004
- A integração da psicofarmacoterapia e psicoterapia de orientação analítica: uma revisão crítica. Revista Brasileira de Psiquiatria. 26:118-123. 2004
- [Ethical aspects involving patient selection in psychiatric research].. Revista Brasileira de Psiquiatria. 25:259. 2003
- Neurobiologia do transtorno de humor bipolar e tomada de decisão na abordagem psicofarmacológica. Trends in Psychiatry and Psychotherapy. 25:88-105. 2003
- Mycoplasma pneumoniae pneumonia: clinical and radiological features. Jornal de Pediatria (Versão em Português). 76:315-22. 2000
- Population-based study on the prevalence of gastroesophageal reflux disease in Porto Alegre, Rio Grande do Sul. GED - Gastrenterologia Endoscopia Digestiva. 19:73-78. 2000
- The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. 73:237-250. 1999
- As bases neurobiológicas do transtorno bipolar. Revista de Psiquiatria Clinica. 32:28-33.
- Brazilian Psychiatric Association consensus for the management of psychiatric emergencies in pregnancy and postpartum period. Debates em Psiquiatria. 12:1-44.
- Tratamento farmacológico do transtorno bipolar: as evidências de ensaios clínicos randomizados. Revista de Psiquiatria Clinica. 32:34-38.
-
preprints
- Brazilian Psychiatric Association consensus for the Management of Psychiatric Emergencies in Pregnancy and Postpartum period 2024
- Large Individual Differences in Functional Connectivity in the Context of Major Depression and Antidepressant Pharmacotherapy 2023
- SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants 2023
- A standardized workflow for long-term longitudinal actigraphy data processing: One year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study 2023
- Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo 2022
- Cerebello-cerebral Functional Connectivity Networks in Major Depressive Disorder: A CAN-BIND-1 Study Report 2021
- Baseline functional connectivity in resting state networks associated with depression and remission status after 16 weeks of pharmacotherapy: A CAN-BIND Report 2021
- Visual QC Protocol for FreeSurfer Cortical Parcellations from Anatomical MRI 2020
- Integrated Genome-Wide Methylation and Expression Analyses Reveal Functional Predictors of Response to Antidepressants 2018